Training of Academic Gynecologic Oncologists

学术妇科肿瘤学家的培训

基本信息

  • 批准号:
    8999433
  • 负责人:
  • 金额:
    $ 46.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-15 至 2021-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): To address the national shortage of academic gynecologic oncologists, the Department of Gynecologic Oncology at The University of M. D. Anderson Cancer Center has dedicated its T32 training program to producing outstanding academic Gynecologic Oncologists-both clinician investigators and physician- scientists. Our T32 trainees develop the research background skills necessary to be productive investigators. Moreover, we are committed to providing T32 training to groups that are underrepresented in academic gynecologic oncology, including minority individuals and women. Our program provides opportunities in a broad range of research training disciplines including, but not limited to, cancer biology, molecular therapeutics, tumor immunology, health disparities, epidemiology, health services research, and clinical trial design/implementation. This 4-year program includes 24 months of research training followed by 24 months of clinical training. Three types of research training are offered: 1) a physician-scientist track in which trainees spend 24 months in the laboratory, 2) a clinical trial list track in which trainees spend 12 months in a laboratory performing drug discovery followed by 12 months in our phase I clinical trial program, and 3) a population-based research track in which trainees spend 24 months under the direction of one or two of the faculty mentors; this track may include one year of laboratory-based research followed by a year of population-based research or two years of population-based research. Additionally, during the research years, each fellow is required to complete a core of three courses and earn an advanced degree - either an M.S. degree or an M.P.H. degree-in the Graduate School of Biomedical Sciences or the UT School of Public Health, respectively. This versatility in academic training increases the likelihood of obtaining an academic position upon completion of training. The mentors in our program - physician-scientists and research scientists with active research programs supported by external peer-reviewed funding are committed to high quality research experience focused on gynecologic cancers. The University of Texas M. D. Anderson Cancer Center vigorously promulgates a core mission of excellence in research, education, and patient care. As a result, this is a highly stimulating environment in which aspiring academic gynecologic oncologists can receive research training under the aegis of the T32 program.
 描述(由申请人提供):为了解决全国学术妇科肿瘤学家短缺的问题,M。D.安德森癌症中心致力于其T32培训计划,以产生优秀的学术妇科肿瘤学家,无论是临床研究人员和医生,科学家。我们的T32学员培养成为富有成效的调查员所需的研究背景技能。此外,我们致力于为学术妇科肿瘤学代表性不足的群体提供T32培训,包括少数民族个人和妇女。我们的计划提供了广泛的研究培训学科的机会,包括但不限于 癌症生物学、分子治疗学、肿瘤免疫学、健康差异、流行病学、卫生服务研究和临床试验设计/实施。这个为期4年的计划包括24个月的研究培训,然后是24个月的临床培训。提供三种类型的研究培训:1)医生-科学家轨道,受训者在实验室中度过24个月,2)临床试验列表轨道,受训者在实验室中度过12个月进行药物发现,然后在我们的I期临床试验计划中度过12个月,(3)以人口为基础的研究途径,学员在一至两名导师的指导下学习24个月;这一轨道可能包括一年的实验室研究,然后是一年的人口研究或两年的人口研究。此外,在研究期间,每个研究员都必须完成三门核心课程,并获得高级学位-无论是硕士学位。学位或硕士学位分别在生物医学科学研究生院或UT公共卫生学院获得学位。学术培训的这种多样性增加了在完成培训后获得学术职位的可能性。我们计划中的导师-医生-科学家和研究科学家,他们的研究计划由外部同行评审资金支持,致力于提供专注于妇科癌症的高质量研究经验。德克萨斯大学M. D.安德森癌症中心大力宣传卓越的研究,教育和病人护理的核心使命。因此,这是一个高度刺激的环境,有抱负的学术妇科肿瘤学家可以在T32计划的支持下接受研究培训。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karen Hsieh Lu其他文献

Karen Hsieh Lu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karen Hsieh Lu', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    7962036
  • 财政年份:
    2010
  • 资助金额:
    $ 46.62万
  • 项目类别:
Metformin for the Chemoprevention of Endometrial Cancer In Obese, Insulin-Resista
二甲双胍用于肥胖、胰岛素抵抗者子宫内膜癌的化学预防
  • 批准号:
    7961962
  • 财政年份:
    2010
  • 资助金额:
    $ 46.62万
  • 项目类别:
Training of Academic Gynecologic Oncologists
学术妇科肿瘤学家的培训
  • 批准号:
    9519959
  • 财政年份:
    2005
  • 资助金额:
    $ 46.62万
  • 项目类别:
Training of Academic Gynecologic Oncologists
学术妇科肿瘤学家的培训
  • 批准号:
    9312243
  • 财政年份:
    2005
  • 资助金额:
    $ 46.62万
  • 项目类别:
Annual Uterine Cancer Symposium
年度子宫癌研讨会
  • 批准号:
    7491238
  • 财政年份:
    2004
  • 资助金额:
    $ 46.62万
  • 项目类别:
Annual Uterine Cancer Symposium
年度子宫癌研讨会
  • 批准号:
    7125061
  • 财政年份:
    2004
  • 资助金额:
    $ 46.62万
  • 项目类别:
Annual Uterine Cancer Symposium
年度子宫癌研讨会
  • 批准号:
    6943173
  • 财政年份:
    2004
  • 资助金额:
    $ 46.62万
  • 项目类别:
Annual Uterine Cancer Symposium
年度子宫癌研讨会
  • 批准号:
    7285647
  • 财政年份:
    2004
  • 资助金额:
    $ 46.62万
  • 项目类别:
Annual Uterine Cancer Symposium
年度子宫癌研讨会
  • 批准号:
    6887939
  • 财政年份:
    2004
  • 资助金额:
    $ 46.62万
  • 项目类别:
M.D. Anderson Gynecologic SPORE for Uterine Cancers
M.D. Anderson 妇科孢子治疗子宫癌
  • 批准号:
    8321100
  • 财政年份:
    2003
  • 资助金额:
    $ 46.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了